If it's NAD+ cream, why are NMN and NR in there?

NAD+ weighs about 663 daltons, too large to cross the stratum corneum efficiently. Instead, formulators deliver smaller precursors (NMN, NR, niacinamide) that skin cells convert into NAD+ internally using their own enzymes.

Is niacinamide the same as NMN?

No. Niacinamide (B3) is the simplest and cheapest NAD+ precursor and is already widely used for barrier support and tone evening. NMN and NR sit closer to NAD+ in the metabolic chain and convert more efficiently, but raw material costs run 10 to 20 times higher.

What is a CD38 inhibitor?

CD38 is an enzyme that breaks down NAD+ and becomes more active with age. Supplying more precursors does not help if CD38 is consuming NAD+ faster than cells can make it. Quercetin (from onion, apple peel) and enoxolone (from licorice root) inhibit CD38, per 2024 PMC research.

Topical NAD+ Is Really NR and NMN, and 2026 Formulas Add a CD38 Blocker

NAD+ (nicotinamide adenine dinucleotide) sits at the center of 2026’s skincare conversation. Known from longevity medicine as the coenzyme that runs mitochondrial function, cellular repair, and DNA maintenance, it is now moving into topical formulations. Behind the marketing phrase “NAD+ cream,” however, sits an important scientific fact.

NAD+ Doesn’t Actually Enter Skin

NAD+ weighs roughly 663 daltons, well above the 500-dalton rule (Bos and Meinardi, 2000) for reliable transdermal penetration through intact stratum corneum. An “NAD+ cream” therefore does not deliver NAD+ itself. It delivers precursors that skin cells use to make NAD+ internally.

The Three Real Actives

Three NAD+ precursors do the actual work in topical products.

Niacinamide (vitamin B3) is the oldest and most universal. At 5% concentration, it has decades of clinical data supporting barrier strengthening, brightening, and sebum control. It enters the NAD+ synthesis chain several steps upstream.

NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) sit two or three steps closer to NAD+ in the metabolic chain and convert more efficiently. Raw material costs run 10 to 20 times higher than niacinamide, and formulas require oxidation protection. The premium NAD+ skincare lines of 2026 are largely differentiating on NR and NMN content.

The Hidden Adversary: CD38

Research published in the International Journal of Molecular Sciences in 2024 (PMC11544843) introduced a new paradigm. CD38 is an NAD-degrading enzyme (NADase) whose activity rises with age in skin. Even abundant precursor supply cannot maintain NAD+ levels if CD38 keeps breaking it down.

The authors identified two plant-derived compounds that inhibit CD38: quercetin, a flavonoid from onion, apple peel, and green tea, and enoxolone, a triterpenoid from licorice root. Combining these with NAD+ precursors improved sirtuin activation, autophagy, and mitochondrial function in skin cells simultaneously.

The implication is clear. Post-2026 NAD+ skincare shifts from the first-generation “supply more precursor” model to a second-generation “supply precursor + inhibit CD38” model.

Joining the Clinical Trend

In 2026’s clinical skincare landscape, NAD+ precursors sit alongside copper peptides and HIFU (high-intensity focused ultrasound) at the core of “skin longevity.” Unlike previous anti-aging generations focused on individual wrinkle reduction, the longevity paradigm targets mitochondrial function, cellular repair capacity, and barrier resilience.

Mitochondrial decline as a central mechanism of skin aging has been established since around 2009. As skin cells lose energy output, collagen synthesis, DNA repair, and keratinocyte regeneration all slow down. Since NAD+ is the central coenzyme of that energy metabolism, maintaining NAD+ levels in skin cells is the theoretical basis for NAD+ skincare.

Reading the Label

Three things to check on an NAD+ skincare label.

First, which precursors. “Contains NAD+” means little. Specific listings of NR, NMN, or niacinamide are meaningful. Second, concentration. Niacinamide at 5% or higher meets clinical benchmarks. NMN and NR can be effective at 1-2% depending on formulation. Third, CD38 inhibitor co-ingredients. Quercetin, enoxolone, and apigenin in the formula mark a second-generation product.

Oral Versus Topical

NAD+ precursors have built a multi-billion-dollar market as oral supplements (NMN and NR capsules). After FDA took a conservative stance on NMN’s supplement status in 2024, the global beauty industry has accelerated the pivot to topical NAD+ skincare as an alternative delivery channel.

Topical and oral operate on different scopes. Topical acts locally on skin. Oral distributes systemically to muscle, brain, and liver. If the goal is skin longevity alone, topical is sufficient. For systemic energy metabolism, oral supplementation remains necessary.

“Applying NAD+” now means running a metabolic strategy that combines precursor supply with CD38 inhibition. Next-generation anti-aging is moving from single-ingredient claims toward designing entire metabolic pathways.

Source: PMC / NBC News Select